In glioblastoma, SOX4 serves as a direct TGF-β target gene, conducts an alternative non-SMAD TGF-β signaling, and induces SOX2 expression to maintain the stemness of glioma-initiating cells [34], [46]. The gene discussed is TGFB1; the disease is glioblastoma.